New resolution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers elevated efficiencies for medical trials
SINGAPORE, June 2, 2025 /PRNewswire/ — Medidata, a Dassault Systèmes model and main supplier of medical trial options to the life sciences {industry}, immediately introduced the launch of Medidata Protocol Optimization, a part of the Medidata Examine Expertise which is obtainable on the Medidata Platform. Medidata is showcasing this novel resolution on the American Society of Scientific Oncology (ASCO) 2025 convention, which might be held from Could 30–June 3, 2025 in Chicago.
Medidata Protocol Optimization, a flagship element of the unified Examine Expertise, transforms trial design and execution by leveraging AI-driven predictive modeling, digital protocols, and industry-leading aggregated knowledge to simulate trial efficiency. This resolution has the power to foretell the influence on affected person burden, web site efficiency, and prices, properly prematurely of the First Affected person In (FPI) leading to analysis groups gaining important foresight into the potential challenges. This method considerably decreases pricey amendments and enrollment delays, resulting in smoother and decrease price trials.
“Oncology trials are among the most intricate and demanding in medical analysis, usually resulting in extra modifications through the research than some other therapeutic space,” stated Dan Braga, senior vice chairman, Examine Expertise, Medidata. “Due to this complexity, we wished to introduce Protocol Optimization at ASCO to present researchers a deeper look into how balancing scientific intention and sensible execution can convey remedies to the market extra successfully.”
To study extra about Protocol Optimization, please go to right here.
About Medidata
Medidata is powering smarter remedies and more healthy individuals via digital options to assist medical trials. Celebrating 25 years of ground-breaking technological innovation throughout greater than 36,000 trials and 11 million sufferers, Medidata provides industry-leading experience, analytics-powered insights, and one of many largest medical trial knowledge units within the {industry}. Greater than 1 million registered customers throughout roughly 2,300 prospects belief Medidata’s seamless, end-to-end platform to enhance affected person experiences, speed up medical breakthroughs, and produce therapies to market sooner. A Dassault Systèmes model (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York Metropolis and has been acknowledged as a Chief by Everest Group and IDC. Uncover extra at www.medidata.com and comply with us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. Since 1981, the corporate has pioneered digital worlds to enhance actual life for shoppers, sufferers and residents. With Dassault Systèmes’ 3DEXPERIENCE platform, 370,000 prospects of all sizes, in all industries, can collaborate, think about and create sustainable improvements that drive significant influence. For extra data, go to: www.3ds.com.
Brand – https://mma.prnewswire.com/media/2699901/Medidata_Logo.jpg
View authentic content material:https://www.prnewswire.com/in/news-releases/medidata-debuts-protocol-optimization-at-asco-leveraging-ai-to-transform-the-study-experience-302469360.html
